Zum Inhalt springen
Technische Universität München

News

Gemcitabine and ATR inhibitors fighting PDAC hand-in-hand!

Navigate through all of your PTM datasets!

Another decryptM story out! Congrats to Yun and co-authors! Our latest study in Cell Reports deciphers KDAC inhibitor action through dose-resolved proteomics (acetylome, phosphoproteome, and full proteome), revealing key insights into drug MoA and enzyme substrate relationships. Explore our dataset…

Prof. Bernhard Kuster is one of them

Congratulations to Johanna Tueshaus

Congrats to Maria!

To top